Abstract The LL-37 5mg peptide pen features a highly purified solution of the only known human cathelicidin antimicrobial peptide. Cleaved from the C-terminus of the hCAP18 precursor protein, LL-37 is an amphipathic, $\alpha$-helical cationic peptide that serves as a critical effector of the innate immune system. This 5mg formulation is specifically engineered for research into antimicrobial resistance (AMR), biofilm eradication, and immunomodulation. It allows researchers to investigate the peptide’s dual mechanism of action: the direct electrostatic disruption of bacterial membranes and the receptor-mediated chemotaxis of neutrophils and monocytes. The 5mg concentration is optimised for determining Minimum Inhibitory Concentrations (MIC) and establishing the cytotoxicity threshold in mammalian cell lines.

Mechanism and Research Interest

Primary Biological Pathway: Membrane Disruption (Toroidal Pore Formation) The fundamental mechanism of LL-37 is its interaction with the anionic phospholipid headgroups of bacterial membranes. Being highly cationic (+6 charge), it binds electrostatically to the negatively charged bacterial surface. Research utilising the 5mg pen focuses on the “Toroidal Wormhole” or “Carpet” models of action, investigating how the peptide inserts into the bilayer to cause rapid depolarisation and lysis. This pathway is of immense interest for developing novel therapeutics against Multi-Drug Resistant (MDR) “ESKAPE” pathogens, as it targets physical structure rather than metabolic pathways.

Secondary Research Finding: Anti-Biofilm Activity LL-37 is a potent inhibitor of biofilm formation. Research demonstrates that sub-inhibitory concentrations of LL-37 can prevent the initial attachment of bacteria (such as Pseudomonas aeruginosa and Staphylococcus aureus) and degrade existing biofilm matrices. The 5mg formulation is critical for biofilm assays (e.g., Crystal Violet staining), allowing researchers to measure the downregulation of quorum-sensing systems (such as Las and Rhl) induced by the peptide.

Tertiary Research Finding: LPS Neutralisation and Sepsis LL-37 binds with high affinity to Lipopolysaccharide (LPS), the primary endotoxin of Gram-negative bacteria. By binding to LPS, LL-37 prevents it from interacting with Toll-like Receptor 4 (TLR4) on host immune cells, thereby dampening the “cytokine storm” associated with sepsis. Researchers use the 10mg format to dose-range this anti-endotoxin effect, specifically looking for reductions in TNF-$\alpha$ and IL-6 release in macrophage models challenged with endotoxin.

Long-term Genomic and Safety Observations While beneficial, LL-37 can be cytotoxic to host cells at high concentrations and is implicated in inflammatory skin disorders like Rosacea (where it is overexpressed). Safety pharmacology studies use the 5mg pen to establish the “therapeutic window”—the concentration range where the peptide kills bacteria without lysing host erythrocytes or keratinocytes. Genomic analysis often targets the Camp gene promoter to understand how Vitamin D3 and histone acetylation regulate endogenous LL-37 expression.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). We ensure the absence of truncated sequences which can significantly alter the amphipathicity and membrane-penetrating capability.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing, which is essential for establishing precise MIC values ($\mu g/ml$) that are reproducible across different bacterial strains.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The LL-37 5mg Pen contains a cationic peptide that is prone to adsorption to glass and plastic surfaces if not formulated correctly. It must be refrigerated (2∘C to 8∘C). The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. Researchers should be aware that LL-37 can self-assemble into oligomers at high concentrations or specific pH levels; maintaining the solution at the recommended temperature is vital to prevent aggregation.

Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to preserve the $\alpha$-helical potential of the peptide, we recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing can induce the formation of large aggregates. In antimicrobial assays, aggregated peptide often loses its ability to penetrate the bacterial cell wall, leading to false-negative susceptibility results. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The LL-37 5mg Pen is the standard for Antimicrobial and Biofilm Research. Handling AMPs (Antimicrobial Peptides) is notoriously difficult; they are “sticky” and often lost to pipette tips or vial walls during manual reconstitution, leading to inaccurate concentration calculations.

Our pre-reconstituted pen ensures that the concentration is verified and stable. It allows researchers to deliver precise aliquots directly into 96-well plates for MIC/MBC assays or biofilm degradation studies, ensuring that the data reflects the true potency of the cathelicidin.

For researchers investigating related tissue repair and immune defense peptides, we recommend examining:

• KPV 10mg:  (For non-microbial anti-inflammatory controls).

• TB-500 10mg: (For comparative wound healing studies).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection, therapeutic use (e.g., for treating infections or eczema), or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.